A Phase 1b Study of Paclitaxel And Ricolinostat For The Treatment Of Gynecological Cancer
Status:
Terminated
Trial end date:
2017-07-28
Target enrollment:
Participant gender:
Summary
Participants with Ovarian, Fallopian Tube, or Peritoneal Cancer that has recurred within 12
months of prior treatment that includes Platinum Chemotherapy are invited to take part in
this study. This research study is studying a combination of a new chemotherapy drug called
Ricolinostat together with the chemotherapy Paclitaxel and a drug called Bevacizumab as a
possible treatment for this diagnosis.